Description

Nevirapine Tablet

Nevirapine Tablets (200 mg) — Antiretroviral (ARV)

Healthy Life Pharma Private Limited, alongside our specialized global marketing and export division Healthy Inc, is a premier manufacturer, supplier, and exporter of advanced antiviral, anti-retroviral (ARV), and public health therapeutics. We manufacture ultra-high-purity, kinetically stable Nevirapine Tablets within our WHO–GMP certified, high-containment solid dosage manufacturing facilities. This foundational “Non-Nucleoside Reverse Transcriptase Inhibitor” serves as a high-volume strategic export to National AIDS Control Programs, state hospital networks, international humanitarian relief organizations, and global B2B wholesale marketplaces across Africa, the CIS region, LATAM, and South-East Asia.

Product Overview

This formulation operates as a “Viral Replication Immobilizer.” It ensures patient safety and stops the spread of HIV-1 within the host body by directly blocking the viral enzyme responsible for translating viral RNA into cellular DNA.

• Mechanism 1 (Non-Competitive Allosteric Binding): Nevirapine physically binds directly and non-competitively to a specific allosteric pocket adjacent to the active catalytic site of the HIV-1 Reverse Transcriptase (RT) enzyme.

• Mechanism 2 (Enzymatic Hydrodynamic Disruption): This physical binding chemically alters the spatial conformation of the enzyme’s active site. By physically disrupting the mobility of the “catalytic palm” region of the enzyme, it completely stops its polymerase activity.

• Mechanism 3 (DNA Chain Synthesis Halt): Because the enzyme is physically paralyzed, it can no longer chemically bind nucleoside triphosphates to build viral DNA from viral RNA, effectively halting the replication cycle of the retrovirus. Note: Nevirapine is highly selective for HIV-1 and does not physically inhibit HIV-2 or human cellular DNA polymerases.

Product Composition & Strengths

We supply this antiretroviral therapeutic in the globally accepted standard therapeutic strength optimized for adult combination maintenance therapy.

Technical & Logistics Specifications

• HS Code: 3004.90.99 (Medicaments acting on infectious diseases / Antivirals / Antiretrovirals)

• CAS Number: 129618-40-2 (Nevirapine)

• Dosage Form: Oral Solid Tablet

• Packaging Configurations: 10 Tablets per Blister packed in premium Alu-Alu (Cold-Form Foil) strips, or 30 / 60 Tablets per induction-sealed HDPE Bottle containing integrated desiccant canisters. Our tropicalized packaging configurations completely shield the active ingredient from moisture ingress and ambient oxygen, guaranteeing a full 36-month shelf life in hot, humid Zone IVb export environments.

Manufacturing Authority & Compliance

• High-Containment Antiviral Separation: Nevirapine is a highly potent active antiretroviral agent that demands strict airborne containment. Our manufacturing process utilizes Dedicated Solid Dosage Lines with Isolated Negative-Pressure Cleanrooms (HVAC), physically ensuring absolute zero cross-contamination with standard drug classes to clear rigid international B2B audits.

• Precision Particle Distribution Blending: Because uneven drug distribution can cause under-dosing—which directly leads to the rapid development of multi-drug viral resistance—we deploy Automated High-Efficiency Geometric Solid Blenders, physically ensuring chemical content uniformity across every batch.

• Kinetic Bioavailability Profiling: Every production batch physically undergoes Comparative In-Vitro Dissolution Profiling, chemically validating that our generic solid doses precisely replicate the kinetic absorption and plasma-clearance curves of global innovator benchmarks (such as Viramune).

Primary Indications

• HIV-1 Management: Part of an appropriate Combination Antiretroviral Therapy (cART) regimen for the treatment of HIV-1 infected adults, adolescents, and pediatric patients.

• Prevention of Mother-to-Child Transmission (PMTCT): Frontline, immediate prevention of vertical HIV-1 transmission from infected mothers to their newborn infants during labor and delivery.

Usage Instructions

• The Crucial Lead-In Dose Phase: Nevirapine has a strict 14-day introductory loading protocol. A single 200 mg tablet must be taken physically once daily for the first 14 days. If no severe skin rashes or hepatic issues occur, the dosage is chemically escalated to the standard maintenance dose of one 200 mg tablet twice daily.

• Administration Guideline: Swallow the tablet physically whole with a full glass of water. It can be taken consistently either with or without food.

• The Adherence Directive: Missing doses physically allows the retrovirus to rapidly adapt and develop chemical resistance against the entire NNRTI drug class. Patients must maintain perfect daily compliance.

Safety Warning: POTENT CRITICAL ANTI-RETROVIRAL (ARV). For Infectious Disease Specialist Supervision Only. Severe Hepatotoxicity Risk: May chemically cause severe, life-threatening Hepatic Failure; physical monitoring of Liver Function Tests ($ALT$/$AST$) is mandatory before and during initial therapy weeks. Skin Reaction Warning: Rare but severe risk of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis; immediately discontinue treatment if any progressive skin rash accompanied by constitutional symptoms occurs. Contraindication: Absolute contraindication in patients with severe hepatic impairment or a known history of severe hypersensitivity reactions to Nevirapine.

Global CDMO Services & Wholesale Supply Chain

Healthy Life Pharma Private Limited and Healthy Inc provide complete, internationally validated Third-Party Contract Manufacturing (CDMO Services) and high-volume private label export supply for generic Nevirapine 200 mg Tablets. Whether you are executing a high-volume procurement contract for an African National HIV/AIDS Control Tender, supplying a public health program in LATAM, or stocking specialized lines on an international digital B2B Pharmaceutical Marketplace across Southeast Asia, we supply all mandatory compliance documentation (WHO-GMP Certificate, Certificates of Pharmaceutical Product – COPP, Certificates of Analysis – COA, Stability Testing Matrix Sheets, and Complete CTD Format Dossier sets) for rapid global registration.

Commercial & Bulk Procurement Inquiries:

• Corporate Head Office: Mumbai, Maharashtra, India

• Primary Manufacturing Base: Boisar, Maharashtra, India

• WhatsApp / Direct Call: +91 7710003340

• Corporate Email: info@healthyinc.co.in